Bristol OTC Stock Valuation

BMYMP
 Stock
  

USD 1,100  0.50  0.0454%   

What is the intrinsic value of Bristol stock? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Bristol Myer, is its stock price multiplied by the total number of shares outstanding, calculating Bristol Myer's enterprise value requires a different approach. It uses Bristol Myer's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Bristol Myer Squi shows a prevailing Real Value of $1213.04 per share. The current price of the firm is $1100.03. At this time, the firm appears to be undervalued. Our model approximates the value of Bristol Myer Squi from analyzing the firm fundamentals such as Profit Margin of 1.74 %, shares outstanding of 1.64 B, and Return On Equity of 2.97 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
Bristol Myer Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Bristol Myer's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Bristol Most Recent Valuation Data

Trailing PE
4.9 K
Undervalued
Today 1,100
Please note that Bristol Myer's price fluctuation is very steady at this time. Calculation of the real value of Bristol Myer Squi is based on 3 months time horizon. Increasing Bristol Myer's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Bristol Myer Squi is useful when determining the fair value of the Bristol otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Bristol Myer. Since Bristol Myer is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bristol OTC Stock. However, Bristol Myer's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
990.03
Downside
1,213
Real Value
1,215
Upside
Estimating the potential upside or downside of Bristol Myer Squi helps investors to forecast how Bristol otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bristol Myer more accurately as focusing exclusively on Bristol Myer's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1,0621,2311,401
Details
Hype
Prediction
LowEstimated ValueHigh
1,0981,1001,102
Details
Potential
Annual Dividend
LowIncome Per ShareHigh
2.322.332.34
Details

Bristol Myer Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Bristol Myer's current stock value. Our valuation model uses many indicators to compare Bristol Myer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bristol Myer competition to find correlations between indicators driving Bristol Myer's intrinsic value. More Info.
Bristol Myer Squi is number one stock in price to book category among related companies. It is number one stock in price to sales category among related companies fabricating about  0.57  of Price to Sales per Price to Book. The ratio of Price to Book to Price to Sales for Bristol Myer Squi is roughly  1.75 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bristol Myer by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bristol Myer's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bristol Myer's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bristol Myer's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bristol Myer and how it compares across the competition.

About Bristol Myer Valuation

The equity valuation mechanism determines the current worth of Bristol Myer Squi on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Bristol Myer Squi. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Bristol Myer Squi based exclusively on its fundamental and basic technical indicators. By analyzing Bristol Myer's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Bristol Myer's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bristol Myer. We calculate exposure to Bristol Myer's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bristol Myer's related companies.
Fiscal Year End
December
Industry
Other
Full Time Employees
23.7 K
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 23700 people.
Bristol Myer's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Bristol Myer's value is low or high relative to the company's performance and growth projections. Determining the market value of Bristol Myer can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Bristol Myer represents a small ownership stake in the entity. As a stockholder of Bristol, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Bristol Myer Dividends Analysis For Valuation

There are various types of dividends Bristol Myer can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Bristol shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Bristol Myer Squi directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Bristol pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Bristol Myer by the value of the dividends paid out.
Continue to Trending Equities. Note that the Bristol Myer Squi information on this page should be used as a complementary analysis to other Bristol Myer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Bristol OTC Stock analysis

When running Bristol Myer Squi price analysis, check to measure Bristol Myer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myer is operating at the current time. Most of Bristol Myer's value examination focuses on studying past and present price action to predict the probability of Bristol Myer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bristol Myer's price. Additionally, you may evaluate how the addition of Bristol Myer to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Is Bristol Myer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myer. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1804.8 B
The market value of Bristol Myer Squi is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myer's value that differs from its market value or its book value, called intrinsic value, which is Bristol Myer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myer's market value can be influenced by many factors that don't directly affect Bristol Myer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myer's value and its price as these two are different measures arrived at by different means. Investors typically determine Bristol Myer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.